Pengsheng Yi

587 total citations
27 papers, 475 citations indexed

About

Pengsheng Yi is a scholar working on Hepatology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Pengsheng Yi has authored 27 papers receiving a total of 475 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hepatology, 12 papers in Surgery and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Pengsheng Yi's work include Hepatocellular Carcinoma Treatment and Prognosis (13 papers), Cancer Mechanisms and Therapy (8 papers) and Liver Disease Diagnosis and Treatment (7 papers). Pengsheng Yi is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (13 papers), Cancer Mechanisms and Therapy (8 papers) and Liver Disease Diagnosis and Treatment (7 papers). Pengsheng Yi collaborates with scholars based in China. Pengsheng Yi's co-authors include Mingqing Xu, Liangliang Xu, Xiaobo Zheng, Ming Zhang, Chuan Lan, Ming Zhang, Ming Zhang, Xiaoqin Zhou, Jing Li and Junning Liu and has published in prestigious journals such as PLoS ONE, Frontiers in Immunology and Molecular Cancer.

In The Last Decade

Pengsheng Yi

23 papers receiving 471 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pengsheng Yi China 10 323 315 106 84 54 27 475
Gyeonghwa Kim South Korea 10 351 1.1× 326 1.0× 43 0.4× 19 0.2× 91 1.7× 20 458
Renfeng Shan China 12 122 0.4× 116 0.4× 90 0.8× 68 0.8× 39 0.7× 27 297
Xinliang Ming China 9 151 0.5× 129 0.4× 55 0.5× 21 0.3× 60 1.1× 12 286
Nicolai Aagaard Schultz Denmark 9 121 0.4× 149 0.5× 79 0.7× 81 1.0× 69 1.3× 21 322
Cheng‐Qian Zhong China 9 95 0.3× 77 0.2× 139 1.3× 56 0.7× 71 1.3× 20 277
Marina Sánchez‐Frías Spain 10 148 0.5× 69 0.2× 48 0.5× 23 0.3× 53 1.0× 25 259
Nutcha Pinjaroen Thailand 11 83 0.3× 86 0.3× 96 0.9× 55 0.7× 121 2.2× 25 284
Linfeng Xu China 10 73 0.2× 64 0.2× 128 1.2× 52 0.6× 63 1.2× 24 251
Xueguo Sun China 10 138 0.4× 123 0.4× 19 0.2× 62 0.7× 34 0.6× 25 292

Countries citing papers authored by Pengsheng Yi

Since Specialization
Citations

This map shows the geographic impact of Pengsheng Yi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pengsheng Yi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pengsheng Yi more than expected).

Fields of papers citing papers by Pengsheng Yi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pengsheng Yi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pengsheng Yi. The network helps show where Pengsheng Yi may publish in the future.

Co-authorship network of co-authors of Pengsheng Yi

This figure shows the co-authorship network connecting the top 25 collaborators of Pengsheng Yi. A scholar is included among the top collaborators of Pengsheng Yi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pengsheng Yi. Pengsheng Yi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Chen, Yi, Xingyu Liu, Jun Yu, et al.. (2025). Risk and prognostic factors of survival for patients with pancreatic ductal adenocarcinoma metastasis to lung: a cohort study. Frontiers in Oncology. 15. 1521616–1521616.
4.
5.
6.
Liu, Junning, et al.. (2024). Salvage liver transplantation versus curative treatment for patients with recurrent hepatocellular carcinoma: A systematic review and meta-analysis. European Journal of Surgical Oncology. 50(7). 108427–108427. 3 indexed citations
7.
Liu, Junning, et al.. (2023). Efficacy and safety of atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a systematic review and meta-analysis. Journal of Cancer Research and Clinical Oncology. 149(17). 16191–16201. 8 indexed citations
8.
9.
Xu, Liangliang, Peng Wang, Li Li, et al.. (2023). circPSD3 is a promising inhibitor of uPA system to inhibit vascular invasion and metastasis in hepatocellular carcinoma. Molecular Cancer. 22(1). 174–174. 11 indexed citations
10.
11.
12.
Li, Hongyu, et al.. (2022). High-throughput circular RNA sequencing reveals the profiles of circular RNA in non-cirrhotic hepatocellular carcinoma. BMC Cancer. 22(1). 857–857. 3 indexed citations
13.
Zhai, Xinyu, et al.. (2022). Effect of statins on risk and mortality of urologic malignancies: Protocol of an umbrella review. PLoS ONE. 17(3). e0264076–e0264076. 1 indexed citations
14.
Yi, Pengsheng, et al.. (2020). Evolution and current status of the subclassification of intermediate hepatocellular carcinoma. World Journal of Gastrointestinal Surgery. 12(3). 85–92. 10 indexed citations
15.
Zhang, Ming, Pengsheng Yi, Xiaobo Zheng, et al.. (2017). Hepatic resection combined with radiofrequency ablation versus hepatic resection alone for multifocal hepatocellular carcinomas: A meta-analysis. Current Medical Science. 37(6). 974–980. 9 indexed citations
16.
Yi, Pengsheng, et al.. (2016). Liver resection for intermediate hepatocellular carcinoma. World Journal of Hepatology. 8(14). 607–607. 14 indexed citations
17.
Xu, Liangliang, Ming Zhang, Xiaobo Zheng, et al.. (2016). The circular RNA ciRS-7 (Cdr1as) acts as a risk factor of hepatic microvascular invasion in hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology. 143(1). 17–27. 266 indexed citations
18.
Yi, Pengsheng, Ming Zhang, & Mingqing Xu. (2016). Role of microRNA in liver regeneration. Hepatobiliary & pancreatic diseases international. 15(2). 141–146. 31 indexed citations
19.
Xu, Liangliang, et al.. (2016). Alvimopan combined with enhanced recovery strategy for managing postoperative ileus after open abdominal surgery: a systematic review and meta-analysis. Journal of Surgical Research. 203(1). 211–221. 38 indexed citations
20.
Yi, Pengsheng, Ming Zhang, & Mingqing Xu. (2015). Management of the middle hepatic vein in right lobe living donor liver transplantation: A meta-analysis. Journal of Huazhong University of Science and Technology [Medical Sciences]. 35(4). 600–605. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gyeonghwa Kim Breakdown of academic impact, for papers by Renfeng Shan Breakdown of academic impact, for papers by Xinliang Ming Breakdown of academic impact, for papers by Nicolai Aagaard Schultz Breakdown of academic impact, for papers by Cheng‐Qian Zhong Breakdown of academic impact, for papers by Marina Sánchez‐Frías Breakdown of academic impact, for papers by Nutcha Pinjaroen Breakdown of academic impact, for papers by Linfeng Xu Breakdown of academic impact, for papers by Xueguo Sun
Rankless by CCL
2026